BOLODEOKU, John; GBAA, Terry; MORRIS, Katherine; WHITEHEAD, Simon. Medicine Optimisation Using PCSK9 Monoclonal Antibodies (alirocumab and evolocumab) Concerning the European Atherosclerosis Society (EAS) of < 1.8 mmol/l LDL Cholesterol Target in a Secondary Care Lipid Clinic. British Journal of Healthcare and Medical Research, [S. l.], v. 10, n. 6, p. 91–102, 2023. DOI: 10.14738/bjhmr.106.15955. Disponível em: https://scholarpublishing.org/journals/index.php/BJHR/article/view/7376. Acesso em: 26 may. 2026.